Innova Captab (NSE:INNOVACAP) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:INNOVACAP Innova Captab Ltd NSE:INNOVACAP
67 GF Score
Price ₹1,038.45
GF Value ₹1,062.11
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Innova Captab FFO per Share?

FFO per Share only applies to REITs.

NSE:INNOVACAP
67GF Score
Innova Captab Ltd NSE:INNOVACAP
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Innova Captab (NSE:INNOVACAP) Overvalued in 2026?

Based on GuruFocus' analysis, Innova Captab stock appears to be undervalued. The current stock price of ₹1,038.45 is trading 2.2% below its estimated GF Value™ of ₹1,062.11. GuruFocus considers Innova Captab to be Fairly Valued.

Key valuation signals for NSE:INNOVACAP:

  • FFO per Share:
  • GF Value™: ₹1,062.11 vs. price of ₹1,038.45 (2.2% below fair value)
  • GF Score™: 67/100 with 6 warning signs

No single metric tells the full story. See the NSE:INNOVACAP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Innova Captab Business Description

Other Exchanges 544067:India
Address Plot No.320, Industrial Area, Phase-1, Panchkula, HR, IND, 134113
Innova Captab Ltd is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company has identified "Drugs and pharmaceutical products" as single operating segment. The company has presence in India, and Outside India. The company generates majority of revenue from India. The company's products are Cephalosporins, Proton Pump Inhibitor, Antocholinergic and Heparin NSAIDs, Analgesics and Antipyretic, Anticold and Antiallergic, Antiemetic, Antidiabetic, Antispasmodic, Antifibrinolytic, Cardiovascular, Antioxidant and Vitamins, Antihyperuricemia and Antigout, Fluoroquinolone and Macrolide, Nootropics and Neurotonics/ Neurotrophics, Antiulcerative, Antimalarial Anxiolytic, Anticonvulsant and Antipsychotic, Bladder and Prostate Disorder, etc.
67GF Score

Get the complete analysis for NSE:INNOVACAP

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,038.45
Price
₹1,062.11
GF Value